We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Polydrug Lands FDA Warning Letter on Post-ban Data Integrity Claims
Polydrug Lands FDA Warning Letter on Post-ban Data Integrity Claims
The FDA has slapped Polydrug Laboratories’ Mumbai facility with a warning letter for alleged GMP deviations seven months after it received a ban on U.S. imports.